About the Authors
- Patrick N. Harter
-
Affiliations Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany, German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany
- Jenny Zinke
-
Affiliation Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany
- Alexander Scholz
-
Affiliation Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany
- Julia Tichy
-
Affiliation Senckenberg Institute of Neurooncology, University of Frankfurt am Main, Frankfurt am Main, Germany
- Cornelia Zachskorn
-
Affiliations Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany, German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany
- Hans M. Kvasnicka
-
Affiliations German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany, Senckenberg Institute of Pathology, University of Frankfurt am Main, Frankfurt am Main, Germany
- Benjamin Goeppert
-
Affiliations German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany, Institute of Pathology, University of Heidelberg, Heidelberg, Germany
- Céline Delloye-Bourgeois
-
Affiliation Apoptosis, Cancer and Development Laboratory, Equipe labellisée ‘La Ligue’, LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France
- Elke Hattingen
-
Affiliation Institute of Neuroradiology, University of Frankfurt am Main, Frankfurt am Main, Germany
- Christian Senft
-
Affiliation Department of Neurosurgery, University of Frankfurt am Main, Frankfurt am Main, Germany
- Joachim P. Steinbach
-
Affiliations German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany, Senckenberg Institute of Neurooncology, University of Frankfurt am Main, Frankfurt am Main, Germany
- Karl H. Plate
-
Affiliations Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany, German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany
- Patrick Mehlen
-
Affiliation Apoptosis, Cancer and Development Laboratory, Equipe labellisée ‘La Ligue’, LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France
- Dorothea Schulte
-
Affiliation Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany
- Michel Mittelbronn
-
* E-mail: michel.mittelbronn@kgu.de
Affiliations Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany, German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany
Competing Interests
The authors have read the journal’s policy and have the following conflicts: Patrick Mehlen declares to have a conflict of interest as founder and shareholder of Netris Pharma. However, this does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: PNH AS HMK BG CDB EH PM DS MM. Performed the experiments: PNH JZ AS JT CZ CDB EH DS. Analyzed the data: PNH JZ AS JT EH CS JPS KHP PM DS MM. Contributed reagents/materials/analysis tools: PNH HMK BG CDB EH CS JPS KHP PM MM. Wrote the paper: PNH AS CDB PM DS MM.